The National Cancer Institute, which recently announced two waves of funding for nanotech training and research, sees nanotechnology as vital to its stated goal of “eliminating suffering and death from cancer by 2015.”

The first cancer nanotech applications will likely involve detection. Nanoparticles could recognize cancer’s molecular signatures, gathering the proteins produced by cancerous cells or signaling the presence of telltale genetic changes.